Problems with the delivery of the ordered amount of vaccines to each EU member state continue to be at the forefront of the ongoing pandemic. The advent of the vaccine was supposed to mark the end of the global pandemic, but with an embarrassingly slow process taking place across the EU, with smaller member states like Croatia suffering the most, it seems that the end is still nowhere near in sight.
Could Ivo Usmiani’s highly successful pharmaceutical company step forward and propose a solution to Croatia’s pressing coronavirus question? Potentially.
As Poslovni Dnevnik writes, the founder and one of the largest shareholders of the Croatian pharmaceutical company Jadran-Galenski laboratorij (JGL), Ivo Usmiani, said that the Croatian pharmaceutical industry has the potential to produce vaccines, and that he is ready to start.
“We have sterile production and we could quickly start producing vaccines, either vector or mRNA types, but only on the condition that we get the license to do so from a vaccine manufacturer,” Ivo Usmiani quite plainly told Vecernji list during a recent interview.
“We have the knowledge and the skills for the production of sterile pharmaceutical forms, as well as the proper technological platform for that. In Rijeka, we also have a Science Centre of Excellence with a dozen quality viral immunologists and molecular biotechnologists, as well as Professor Stipan Jonjic, all of whom deal with vector vaccines, and with whom we often cooperate and with whom we could achieve strong synergies,” added Ivo Usmiani.
For current information on travel, border rules, measures, testing centres and all things coronavirus specific to Croatia, click here.